Infective Endocarditis Flashcards

1
Q

Definition

A
  • Infective Endocarditis is an Infection of the Endocardial Surface of the Heart: Endovascular Infection of Cardiovascular structures, including Cardiac Valves, Atrial and Ventricular Endocardium, Septal Defect, Large Intrathoracic Vessels and Intracardiac Foreign Bodies, such as Prosthetic Valves, Pacemaker Leads and Surgical Conduits.
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Epidemiology

A
  • The annular incidence in the UK is 3-10/100,000 but higher in developing countries.
  • Men are 2.5 x more likely to be affected than women
  • In hospital Mortality 15-30%
  • 95% left side of heart
  • 50% subacute
  • IE is a relatively uncommon infection, but carrie ssignficiant complications (Septic, Shock, Embolic Disease including Stroke, Valvular HF)
  • Without treatment, Mortality approaches 100% ie it is inevitably fatal; even with treatment there is a significant Morbidity and Mortality
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Aetiology

A
  • Endocarditis is usually the consequence of 2 factors: The Presence of Organisms in the Bloodstream, and Abnormal Cardiac Endothelium that facilitates their Adherence and Growth
  • Bacteremia may arise for Patient-Specific Reasons (Poor Dental Hygiene, IV Drug use), Soft Tissue Infections)
  • OR may be a/w Diagnostic or Therapeutic Procedures (Dental Tx, Intravascular Cannulae, Cardiac Surgery or Permanent Pacemakers)
  • Previously damaged tissue (previous IE, Surgery) or Non-Native Structures (Valve Replacement) are predisposed to infection
    • Damaged Endocardium promotes Platelet and Fibrin Deposition which allows Organisms to Adhere and Grow, leading to an Infected Vegetation
    • So Valves/Endocardial surfaces become infected after exposure to micoemboli from Bacteria or fungi circulating in the bloodstream)
  • Certain Bacteria have Virulence factors or Adherence factors that increase likelihood of colonization of tissue
  • Organisms Prolieferate int eh evolving thrombus and their persistent shedding into the Bloodstream causes Immune Response resulting in symptoms
  • Valvular Lesions may create Non-Laminar Flow, and Jet Lesions from Septal Defects or a PDA result in Abnormal Vascular Endothelium
  • Aortic and Mitral Valves are most commonly involved in IE; IVDU are the exception, as Right-Sided Lesions are more common in these patients
  • The Epidemiological Profile of IE has changed over the last few years
    • Newer factors, such as valve Prosthesis, IVDU and Intra-Cardiac Devices are associated with increased use of Invasive Procedures increasing the risk for Opportunistic Bacteremia
  • Healthcare-Acquired IE is a growing demographic representing up to 30% of IE, justifying the use of Aseptic measures during Venous Catheter procedures and any Invasive Procedures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk Factors: Sources of Bacteremia

A
  1. IVDU
  2. Surgical Procedure
  3. Termination of Pregnancy
  4. Age >60
  5. Structural Heart Disease
  6. Valvular HD
  7. Previous Endocarditis
  8. Chronic Hemodialysis
  9. Immunocompromised Individuals (Fungi increased prevalence)
  10. Bowel Cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Organisms

A
  • Staphylococci (30-50%)
    • S. Aureus (31%); most aggressive organism
    • Coagulase Negative Staph (11%)
    • Mitral > Aortic
    • S. Epidermis + Auereus most common in Prosthetic Valve
  • Streptococi 20-30%
    • Strep Viridans (most common, and seen in Subacute disease)
    • Strep. Sanguis, Strep Mitis, Strep Mutans, Strep Milleri
  • Enterococal Endocarditis
    • Enterococcus Faecalis, Enterococcus Faecium
    • a/w Lower GI or GU Disease and Bowel Malignancy or after Invasive Procedures
    • Males > Females
  • Fungi
    • Candida, Aspergillus, Histoplasma
    • Immunocompromised patients
  • Rare causes -→ These include the HACEK group of organisms, which tend to run a more insidious course (Box 30.45).
    • Haemophilus spp
    • Actinobacillus sp
    • Cardiovacterium Hominis
    • Eikenella Corredens
    • Kingella King
  • Culture Negativ eEndocarditis
    • This account for 5-10% of Endocarditis cases
    • The usual cause is Prior Antibiotic Therapy (Good History Taking is vital) but some cases are due to a variety of Fastidious Organisms that fail to grow in normal blood cultures.
    • These include Coxiella burnetii
      (the cause of Q fever), Chlamydia species, Bartonella species (organisms that cause trench fever and cat scratch disease) and Legionella.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Dukes Criteria: Definite diagnosis of IE

A
  1. Pathologival evidence on Histological examination of a Vegetation or an Intracardiac Abscess
  2. 2 major criteria
  3. 1 major and 3 minor
  4. 5 minor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Dukes Criteria: Possible IE

A
  1. 1 major criteria with 1 minor
  2. 3 minor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Modified Duke Criteria for Endocarditis: Major

A
  1. Typical Organisms from 2 separate BC → A Positive Blood Culture for IE, as defined by the recovery of a typical microorganism from Two separate blood cultures in the absence of a primary focus (Viridans Streptococci, Abiotrophia species and Granulicatella species; Streptococcus Bovis, HACEK Group B, or Community-Acquired Staphylococcus Aureus or enterococcus species)
  2. OR Microorganisms consistent with IE from persistently Positive BC → A persistently Positive Blood Culture, defined as the recovery of a microorganism consistent with endocarditis either from blood samples obtained more than 12 h apart or from all three or a majority of four or more separate blood samples, with the first and last obtained at least 1 h apart
  3. or SINGLE positive BC for Coxiella Burnetti → A positive serological test for Qfever , with an immunofluorescence assay showing phase 1 immunoglobulin G antibodies at a titre >1:800
  4. or Echocardiographic evidence of endocardial involvement:
    1. Vegetation: an Oscillating Intracardiac mass on the valve or supporting structures, in
      the path of regurgitant jets, or on implanted material in the absence of an
      alternative anatomical explanation
    2. or an abscess
    3. Or Pseudoaneurysm
    4. or New partial dehiscence of a prosthetic valve
    5. or New valvular regurgitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Modified Duke Criteria for Endocarditis: Minor

A
  1. Predisposition: Predisposing Heart Condition or IVDU
  2. Fever: Temperature ≥38°C(100.4°F)
  3. Vascular Phenomena: Major Arterial Emboli, Zeptic Pulmonary Infarcts, Mycotic
    Aneurysm, Intracranial Haemorrhage, Conjunctival Haemorrhages, Janeway Lesion
  4. Immunological Phenomena: Glomerulonephritis, Oslernodes, Roth Spots, Rheumatoid factor
  5. Microbiological Evidence: a positive blood culture but not meeting a major criterion as noted earlier, or serological evidence of an active infection with
    an organism that can cause infective endocarditisc
  6. Echocardiogram: findings consistent with infective endocarditis but not meeting a major criterion as noted earlier
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical Fx:

A
  • The clinical presentation of IE is dependent on the Organism and the presence of Predisposing Cardiac Conditions.
  • Infective Endocarditis may occur as an Acute, Fulminating infection but also as a Chronic or Subacute Illness with Low-Grade Fever and non-specific sx.
  • Fever (90%) + Night Sweats → Most common presenting complaint. High temperatures associated with IE (>38 degrees). Ask about previous Viral Prodromal Sx
  • Anorexia and Wt. Loss (Quantify the wt. loss
  • Myalgia and Arthralgia (Muscle Pain and Joint pain are non specific
  • SOB → May have some exceptional Dyspnoea secondary to HF. Indicative of Advanced disease
  • A high index of clinical suspicion is required to identify patients with IE and certain criteria should alert the physician
  • High clinical suspicion
    • New valve lesion/(regurgitant) murmur.
    • Embolic event(s) of unknown origin.
    • Sepsis of unknown origin.
    • Haematuria, glomerulonephritis and suspected renal infarction.
    • ‘Fever’ plus:
      • Prosthetic material inside the heart
      • Other high predisposition for infective endocarditis, e.g. intra-venous drug use
      • Newly developed ventricular arrhythmias or conduction dis-turbances
      • First manifestation of congestive cardiac failure
      • Positive blood cultures (with typical organism)
      • Cutaneous (Osler, Janeway) or Ophthalmic (Roth) lesions (Fig.30.90)
      • Peripheral abscesses (renal, splenic, spine) of unknown origin
      • Predisposition and recent diagnostic/therapeutic interven-tions known to result in significant bacteraemia.
    • Low clinical suspicion → Fever plus none of the above.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Examination

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ddx

A
  • Sepsis (non-cardiac(
  • Cardio-Embolic Disease (AFib, Aortic Arch Thrombus)
  • DIC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IX

A
  • The mainstays of diagnosis of IE are Blood Cultures and ECHO, performed in order to identify the Organism, Ensure Appropriate Therapy and Monitor the patients’s Response to therapy
  • Echocardiography is an extremely useful tool if used appropriately but is NOT an appropriate SCREENING test for patients with just a fever or an isolated positive blood culture where there is a low pre-test probability of endocarditis.
  • A negative echocardiogram DOES NOT EXCLUDE a diagnosis of endocarditis and TOE and CT-PET may be required, particularly in cases of Suspected Prosthetic Valve infection.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management

A
  • The Location of the infection means that Prolonged courses of Antibx are usually required
  • The combination of Antibx may be Synergistic in Eradicating Mciorbial Infection and Minimizing Resistance
  • BC should be taken prior to Empirical Antibx therapy (but this should not delay therapy in unstable patients)
  • Antibx tx should continue for 4-6 weeks
  • Typicaly therapeutic Regimens are shown but advice on specific therapy should be sought from the Local Microbiology department according to the organism identified and current sensitivities.
  • Serum Levels of Gentamicin and Vancomycin need to be mounted to ensure adequate therapy and prevent Toxicity
  • In px with Penicillin Allergy, one of the Glycopeptide Antibiotics, Vancomycin or Teicoplanin, can be sued.
    • Penicillins, however are fundamental to the Therapy of Bacterial Endocarditis. Allergies therefore seriously compromise the choice of antibiotcs
    • It is essential to confirm the nature of a pettish allergy to ensure the appropriate tx is not withheld needlessly
    • Anaphylaxis would be much more ingluential on antibx choice than simplee GI disturbance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Regime Choices

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Response to Tx

A
  • More patients with IE should respond within 48 hours of initiation of appropriate Antibx therapy, as evidenced by a Resolution fo Fever, Reduction in Serum Markers of Infection, and Relief of Systemic Symptoms of infection
  • Failure of these factors to occur needs to be taken very seriously (persistent fever)
17
Q

Persistent Fever

A
  • The following should be considered:
  • Perivalvular Extension of Infection and Possible Abscess Formation
  • Drug Reaction (the Fever should resolve promptly after drug withdrawal)
  • HAI (i.e. Venous access site, UTI)
  • PE (Secondary Right-Sided Endocarditis or Prolonged Hospitalization)
18
Q

Persistent Fever Management

A
  • In such cases, samples for culture should be taken from all possible sites and evidence sought of the above causes.
  • A change of antibiotic dosage or regimen should be avoided unless there are positive cultures or a drug reaction is suspected.
  • Emergence of bacterial resistance is uncommon.
  • Close liaison with the microbiology department is recommended and a Cardiothoracic Surgical opinion should be sought
19
Q

Surgery

A
  • Decisions about surgical intervention in patients with infective endocarditis should be made after joint consultation between the Cardiologist and Cardiothoracic Surgeon, taking into account patient-specific features (Age, Non-cardiac morbidities, Presence of Prosthetic material or cardiac failure) and Infective Endocarditis features (Infective Organism, Vegetation Size, Presence of Perivalvular Infection, Systemic Embolization).
20
Q

Prevention: High Risk Groups

A
  • In 2015 the ESC produced guidelines for the management of infec- tive endocarditis.
  • They identified three groups of patients who could be considered at highest risk of developing infective endocarditis and who suffered significant morbidity and mortality complications from it:
  • Those who have Prosthetic Valves (including Transcatheter De- vices) or Material used for valve repair
  • Those with a Previous Episode of IE
  • Those with Uncorrected Cyanotic Congenital Heart disease or who have received palliative shunts. Patients who have Successful Corrective surgery are at high risk for the first 6 months postop- eratively.
21
Q

Prevention Recommendation

A
  • The ESC recommends that these groups should receive antibi-otic prophylaxis during high-risk procedures.
    • This includes dental procedures that involve manipulation of the gingival or periapical part of the teeth or perforation of the oral mucosa. (The American Heart Association also considers that cardiac transplant patients with valvular heart disease should be included as highest-risk patients.)
  • The The ESC also provided additional recommendations applicable to all patients with valvular heart disease (including the highest-risk patients). These include:
    • Regular dental check-ups (6 months for the highest-risk groups and 12 months for all others)
    • Disinfection of wounds and Eradication of chronic Bacterial Carriage (skin, urine)
    • Curative antibiotics for any focus of Bacterial infection
    • No self-medication with antibiotics
    • Strict infection control during at-risk procedures
    • Avoidance of Piercings/Tattoos
    • Limitation of the usage of Infusion Catheters, Preferring Peripheral versus Central Catheters; Peripheral Catheters should be changed every 3-4 days
22
Q

Diagnostic IX: Bloods

A
  1. Blood Cultures
    1. Multiple BC are required for Duke’s diagnostic criteria
    2. Typical Organisms from 2 separate BC
    3. OR Microorganisms consistent with IE from persistently Positive BC
23
Q

Diagnostic IX: Imaging

A
  1. ECHO
    1. TTE initial investigation of choice
    2. TOE if:
      1. Prosthetic Valve/Intracradiac Device
      2. Poor Quality TTE
      3. Positive ‘tte
      4. Negative TTE with HIGH Clinical Suspicion
  2. Cardiac CT → Useful if diagnosis is unclear
  3. FDG-PET/CT → Useful in Prosthetic Valves, must be implanted >3/12 minimum, or can be falsely Positive
24
Q

Aetiological Investigations and Investigations for Complications:

Bloods

A
  1. FBC + CRP → Raised Inflammatory markers and White Cells
  2. U+E → AKI secondary to Septic Emboli
  3. LFT → Acute Liver Injury secondary to Emboli
  4. MSU and Urinalysis → Source of Sepsis, Screening for Hematuria and Signs of Kidney Injury
25
Q

Aetiological Investigations and Investigations for Complications:

Imaging

A
  1. CXR → Cavitating Lesion/Multifocal Pneumonia, Screening for CCF
  2. CT/MRI → Emboli, Infarcts, or Mycotic Aneurysms
26
Q

Aetiological Investigations and Investigations for Complications:

Procedures

A

ECG → Evidence of Heart Block